CRY1 Antibody

Shipped with Ice Packs
In Stock

Description

Research Applications

CRY1 antibodies have been pivotal in uncovering the protein’s dual roles in circadian biology and oncogenesis:

  • Circadian Regulation: CRY1 antibodies confirmed its interaction with CLOCK/BMAL1 heterodimers, essential for feedback repression in circadian oscillations .

  • Cancer Mechanisms:

    • Prostate Cancer: CRY1 overexpression correlates with androgen receptor (AR)-mediated DNA repair and poor clinical outcomes. Antibodies identified CRY1 stabilization post-genotoxic stress, enhancing homologous recombination (HR) repair .

    • Cervical Cancer: CRY1 overexpression linked to chemoresistance and poor survival. CRY1 knockdown via siRNA reduced NANOG expression and activated p53 signaling .

    • Breast Cancer: CRY1 antibodies revealed its role in suppressing YAP/TAZ oncogenic activity and modulating Hippo pathway kinases .

Validation Data

CRY1 antibodies undergo rigorous validation:

  • Western Blot: Detects CRY1 at ~60–66 kDa in human and mouse tissues .

  • Immunocytochemistry: Nuclear localization confirmed in fibroblasts and cancer cell lines .

  • Functional Assays: CRY1 ablation reduced HR repair efficiency by 3.9-fold in U2OS-DR-GFP reporter cells .

Table: CRY1 Antibody Performance in Key Studies

Study FocusAntibody SourceKey Finding
DNA Repair in Prostate CancerProteintech CRY1 binds HR gene promoters (e.g., RAD51, BRCA1) post-DNA damage .
Chemoresistance in Cervical CancerAbcam CRY1/NANOG co-expression predicts poor survival (HR = 2.1, p < 0.01) .
Circadian Feedback LoopMBL Life Science CRY1 Δ11 mutant showed enhanced nuclear localization and BMAL1 binding .

Clinical Relevance

  • Prognostic Marker: CRY1 overexpression in metastatic prostate cancer associates with advanced stage and resistance to genotoxic therapies .

  • Therapeutic Target: CRY1 stabilizers (e.g., KL001) enhance DNA damage-induced cell cycle arrest, while inhibitors sensitize tumors to radiation .

Technical Considerations

  • Storage: Stable at -80°C (Proteintech) or -20°C (MBL) in PBS/glycerol buffers .

  • Cross-Reactivity: MBL’s Anti-Cry1 (PM081) detects both mouse and human CRY1 .

  • Antigen Retrieval: Required for IHC in formalin-fixed tissues .

Product Specs

Buffer
Preservative: 0.03% ProClin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 weeks (Made-to-order)
Synonyms
CRY1 antibody; BLU1 antibody; HY4 antibody; At4g08920 antibody; T3H13.14 antibody; T3H13.5Cryptochrome-1 antibody; AtCry antibody; Atcry1 antibody; Blue light photoreceptor antibody; Protein BLUE LIGHT UNINHIBITED 1 antibody; Protein ELONGATED HYPOCOTYL 4 antibody; Protein OUT OF PHASE 2 antibody; OOP2 antibody
Target Names
CRY1
Uniprot No.

Target Background

Function

This antibody targets Cryptochrome 1 (CRY1), a photoreceptor protein crucial for mediating various blue light responses in plants. CRY1's functions encompass inhibition of hypocotyl elongation, photoperiodic control of flowering, and regulation of diverse light-dependent processes. These include circadian rhythms, tropic growth, stomatal opening, guard cell development, root development, responses to biotic and abiotic stresses, cell cycles, programmed cell death, apical dominance, fruit and ovule development, seed dormancy, and even magnetoreception.

Upon photoexcitation by blue light, CRY1 undergoes a conformational change and interacts with signaling partners to modulate gene expression at both transcriptional and post-translational levels, thereby controlling associated metabolic and developmental pathways. CRY1's blue light absorption involves a flavin photoreduction process facilitated by an electron transport chain or alternative pathways utilizing metabolites like NADPH, NADH, and ATP. The activated signaling state exhibits a half-life of approximately 5 minutes. CRY1 also plays a role in sensing blue/green light ratios, enabling adaptation to varying light conditions (e.g., shade). In darkness, flavin reoxidation returns CRY1 to its inactive state.

CRY1 directly interacts with bHLH transcription factors (PIF4 and PIF5) under low blue light (LBL) conditions, stimulating their activity and influencing gene expression to adjust physiological responses such as hypocotyl elongation and hyponastic growth. High-intensity blue light activates CRY1's capacity for converting molecular oxygen to reactive oxygen species (ROS) and hydrogen peroxide, potentially leading to cell death. CRY1 is essential for blue light-triggered and singlet oxygen-mediated programmed cell death (PCD).

CRY1 is involved in inducing the expression of photoprotective genes under extreme light conditions, mediating blue light-induced gene expression and hypocotyl elongation via modulation of transcription factor degradation and anion channel activation. It plays a critical role in hypocotyl hook formation, stomatal opening, and the regulation of various growth parameters, possibly through auxin and abscisic acid (ABA) signaling. CRY1 further influences lateral root growth and shade avoidance syndrome (SAS), working in conjunction with phototropins to regulate phototropism, and affecting shoot regeneration in vitro. It modulates anthocyanin and chlorophyll accumulation in a PHY-dependent manner, contributes extensively to blue light deetiolation responses, and exhibits characteristics suggestive of a role in magnetoreception. CRY1 also participates in strigolactone signaling, temperature-dependent growth regulation, and disease resistance mechanisms, including systemic acquired resistance (SAR).

Gene References Into Functions

The following studies provide further insights into CRY1 function:

  1. FIN219 and CRY1 negatively regulate each other via direct interaction in response to jasmonate under blue light. PMID: 29561841
  2. A CRY-BIC negative-feedback circuitry regulates the activity of CRY1 and BIC. PMID: 28833729
  3. The cry1 mutation L407F displays hyperactivity, potentially due to structural alterations near the ATP-binding site, rather than altered FADH occupancy. PMID: 28634231
  4. Nitrogen signaling modulates CRY1 protein abundance and influences circadian clock regulation of flowering. PMID: 27325772
  5. 3-bromo-7-nitroindazole (3B7N) specifically interrupts cryptochrome function in seedling development. PMID: 28011868
  6. Cellular metabolites significantly influence cryptochrome signaling. PMID: 26313597
  7. CRY1 inhibits hypocotyl elongation via CNT1-mediated repression of auxin/BR/GA-responsive gene expression. PMID: 25721730
  8. CRY1 activation leads to reactive oxygen species formation and induces cell death. PMID: 25728686
  9. ATP binding and aspartate protonation enhance photoinduced electron transfer in CRY1. PMID: 25157750
  10. Photoreduction-deficient Trp-triad mutations in CRY1 retain physiological and biochemical activity. PMID: 26106155
  11. The in vivo half-lives of the signaling states of cry1 and cry2 are estimated to be around 5 and 16 minutes respectively. PMID: 23398192
  12. PhyA, cry1, and phyB activate ROC1, modulating brassinosteroid signaling during deetiolation. PMID: 22463079
  13. The kinetics and quantum yields of photo-induced flavin-tryptophan radical pairs in cryptochrome are magnetically sensitive. PMID: 22421133
  14. A conserved glycine substitution in the PHR domain of CRY1 confers a constitutive light response. PMID: 21765176
  15. CRY1 is required for blue light shade-avoidance responses, through mechanisms distinct from phyB inactivation. PMID: 21457375
  16. Photoexcitation induces a significant conformational change in AtCRY1. PMID: 21875594
  17. Molecular dynamics simulations suggest the L407F mutation reduces structural flexibility in CRY1. PMID: 20926618
  18. CRY1 restrains lateral root growth by inhibiting auxin transport. PMID: 20133010
  19. cry1 mutants show reduced mRNA expression changes in response to blue and red light. PMID: 20031923
  20. A light-induced conformational change in the carboxy-terminal domain of Arabidopsis Cry1 supports proposed conformational rearrangements in response to light. PMID: 15751956
  21. Light-induced flavin reduction via the tryptophan chain is a primary step in CRY1 signaling. PMID: 15774475
  22. Blue light modifies CNT1 dimer properties, influencing CCT1 activation and CRY1 signaling. PMID: 15805487
  23. Primary root elongation in blue light may involve CRY1-auxin signaling pathway interactions. PMID: 16703358
  24. Cryptochrome-1 activation triggers blue-light-specific apoptosis, independent of chloroplast reactions. PMID: 17075038
  25. Flavin photoreduction-mediated CRY1 activation is a reversible process. PMID: 17237227
  26. Different subcellular pools of CRY1 exhibit distinct functions. PMID: 18003924
  27. New cry1 alleles were identified from a screen for Arabidopsis thaliana genomes uncoupled mutants. PMID: 18065688
  28. Cryptochromes positively affect phototropic curvature under long-term irradiation, particularly in phot1-deficient backgrounds. PMID: 18183416
  29. Genetic analysis indicates independent action of CRYPTOCHROME1 and 5PTase13. PMID: 18252844
  30. CRY1 stabilizes BIT1 in a blue light-dependent manner. PMID: 18397371
  31. HFR1, regulated by cry1, is crucial for early blue light signaling. PMID: 18974779
  32. CRY1-dependent plastid signals regulate cotyledon expansion and development. PMID: 19140931

Database Links

KEGG: ath:AT4G08920

STRING: 3702.AT4G08920.1

UniGene: At.27730

Protein Families
DNA photolyase class-1 family
Subcellular Location
Cytoplasm. Nucleus. Nucleus, PML body.
Tissue Specificity
Widely expressed. Expressed in the aerial tissues (e.g. cotyledons and leaf primordia), but not detected in the roots.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.